On the stability of the soluble amyloid aggregates

Biophysical Journal

Volumn 97, Issue 5, 2009, Pages 1454-1460

  Sahoo, Bankanidhi ^a   Nag, Suman ^a   Sengupta, Parijat ^b   Maiti, Sudipta ^a  

^a TATA INSTITUTE OF FUNDAMENTAL RESEARCH   (India)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; NANOPARTICLE;

ARTICLE; COLLOID; ELECTRICITY; HYDROPHOBICITY; IONIC STRENGTH; PARTICLE SIZE; PH MEASUREMENT; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN STABILITY;

AMYLOID BETA-PEPTIDES; BACILLUS; BACTERIAL PROTEINS; HUMANS; HYDROGEN-ION CONCENTRATION; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LINEAR MODELS; MODELS, BIOLOGICAL; NANOPARTICLES; NONLINEAR DYNAMICS; OSMOLAR CONCENTRATION; PEPTIDE FRAGMENTS; PROTEIN MULTIMERIZATION; PROTEIN STABILITY; SPECTROMETRY, FLUORESCENCE; STATIC ELECTRICITY; THIAZOLES;

EID: 70349587461     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2009.05.055     Document Type: Article

References (48)

1. Selkoe, D. J. 1991. The molecular pathology of Alzheimer's disease. Neuron. 6:487-498.
2. Selkoe, D. J. 2001. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81:741-766.
3. Teplow, D. B. 1998. Structural and kinetic features of amyloid b-protein fibrillogenesis. Amyloid. 5:121-142.
4. Irvine, G. B., O. M. El-Agnaf, G. M. Shankar, and D. M. Walsh. 2008. Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases. Mol. Med. 14:451-464.
5. Chiti, F., and C. M. Dobson. 2006. Protein misfolding: functional amyloid and human disease. Annu. Rev. Biochem. 75:333-366.
6. Selkoe, D. J. 2008. Soluble oligomers of the amyloid b-protein impair synaptic plasticity and behavior. Behav. Brain Res. 192:106-113.
7. Garai, K., B. Sahoo, S. K. Kaushalya, R. Desai, and S. Maiti. 2007. Zinc lowers amyloid β-toxicity by selectively precipitating aggregation intermediates. Biochemistry. 46:10655-10663. (Pubitemid 47417258)
8. Glabe, C. G., and R. Kayed. 2006. Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis. Neurology. 66:S74-S78.
9. Selkoe, D. J. 2008. Biochemistry and molecular biology of amyloid β-protein and the mechanism of Alzheimer's disease. Handbook Clin. Neurol. 89:245-260.
10. Glabe, C. G. 2008. Structural classification of toxic amyloid oligomers. J. Biol. Chem. 283:29639-29643.
11. Walsh, D. M., A. Lomakin, G. B. Benedek, M. M. Condron, and D. B. Teplow. 1997. Amyloid b-protein fibrillogenesis. Detection of a protofibrillar intermediate. J. Biol. Chem. 272:22364-22372.
12. Walsh, D. M., D. M. Hartley, Y. Kusumoto, Y. Fezoui, M. M. Condron, et al. 1999. Amyloid b-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J. Biol. Chem. 274:25945-25952.
13. Garai, K., P. Sengupta, B. Sahoo, and S. Maiti. 2006. Selective destabilization of soluble amyloid b-oligomers by divalent metal ions. Biochem. Biophys. Res. Commun. 345:210-215.
14. Perutz, M. F., and A. H. Windle. 2001. Cause of neural death in neurodegenerative diseases attributable to expansion of glutamine repeats. Nature. 412:143-144.
15. Ferrone, F. A. 2006. Nucleation: the connections between equilibrium and kinetic behavior. Methods Enzymol. 412:285-299.
16. 1-40) is thermodynamically soluble at physiological concentrations. Biochemistry. 42:10506-10513.
17. Lomakin, A., D. S. Chung, G. B. Benedek, D. A. Kirschner, and D. B. Teplow. 1996. On the nucleation and growth of amyloid-protein fibrils: detection of nuclei and quantitation of rate constants. Proc. Natl. Acad. Sci. USA. 93:1125-1129.
18. Jarrett, J. T., E. P. Berger, and P. T. Lansbury, Jr. 1993. The carboxy terminus of the β-amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry. 32:4693-4697.
19. Garai, K., B. Sahoo, P. Sengupta, and S. Maiti. 2008. Quasihomogeneous nucleation of amyloid-β yields numerical bounds for the critical radius, the surface tension, and the free energy barrier for nucleus formation. J. Chem. Phys. 128:045102-045107.
20. Hortschansky, P., V. Schroeckh, T. Christopeit, G. Zandomeneghi, and M. Fandrich. 2005. The aggregation kinetics of Alzheimer's β-amyloid peptide is controlled by stochastic nucleation. Protein Sci. 14:1753-1759. (Pubitemid 40994145)
21. Groenewold, J., and W. K. Kegel. 2001. Anomalously large equilibrium clusters of colloids. J. Phys. Chem. B. 105:11702-11709.
22. Sciortino, F., S. Mossa, E. Zaccarelli, and P. Tartaglia. 2004. Equilibrium cluster phases and low-density arrested disordered states: the role of short-range attraction and long-range repulsion. Phys. Rev. Lett. 93:055701.
23. Stradner, A., H. Sedgwick, F. Cardinaux, W. C. Poon, S. U. Egelhaaf, et al. 2004. Equilibrium cluster formation in concentrated protein solutions and colloids. Nature. 432:492-495. (Pubitemid 39576527)
24. Shukla, A., E. Mylonas, E. Di Cola, S. Finet, P. Timmins, et al. 2008. Absence of equilibrium cluster phase in concentrated lysozyme solutions. Proc. Natl. Acad. Sci. USA. 105:5075-5080.
25. Maiti, S., U. Haupts, and W. W. Webb. 1997. Fluorescence correlation spectroscopy: diagnostics for sparse molecules. Proc. Natl. Acad. Sci. USA. 94:11753-11757.
26. Haupts, U., S. Maiti, P. Schwille, and W. W. Webb. 1998. Dynamics of fluorescence fluctuations in green fluorescent protein observed by fluorescence correlation spectroscopy. Proc. Natl. Acad. Sci. USA. 95:13573-13578.
27. Sengupta, P., K. Garai, J. Balaji, N. Periasamy, and S. Maiti. 2003. Measuring size distribution in highly heterogeneous systems with fluorescence correlation spectroscopy. Biophys. J. 84:1977-1984. (Pubitemid 36322960)
28. Gast, K., A. J. Modler, H. Damaschun, R. Krober, G. Lutsch, et al. 2003. Effect of environmental conditions on aggregation and fibril formation of barstar. Eur. Biophys. J. 32:710-723.
29. Kumar, S., S. K. Mohanty, and J. B. Udgaonkar. 2007. Mechanism of formation of amyloid protofibrils of barstar from soluble oligomers: evidence for multiple steps and lateral association coupled to conformational conversion. J. Mol. Biol. 367:1186-1204.
30. Mukhopadhyay, S., P. K. Nayak, J. B. Udgaonkar, and G. Krishnamoorthy. 2006. Characterization of the formation of amyloid protofi- brils from barstar by mapping residue-specific fluorescence dynamics. J. Mol. Biol. 358:935-942.
31. Juneja, J., N. S. Bhavesh, J. B. Udgaonkar, and R. V. Hosur. 2002. NMR identification and characterization of the flexible regions in the 160 kDa molten globule-like aggregate of barstar at low pH. Biochemistry. 41:9885-9899. (Pubitemid 34839736)
32. Wintrode, P. L., Y. V. Griko, and P. L. Privalov. 1995. Structural energetics of barstar studied by differential scanning microcalorimetry. Protein Sci. 4:1528-1534.
33. Ermakova, E. 2007. Brownian dynamics simulation of the competitive reactions: binase dimerization and the association of binase and barstar. Biophys. Chem. 130:26-31.
34. Magde, D., E. Elson, and W. W. Webb. 1974. Fluorescence correlation spectroscopy. II. An experimental realization. Biopolymers. 13:29-61.
35. Elliot, L., and D. M. Elson. 1974. Fluorescence correlation spectroscopy. I. Conceptual basis and theory. Biopolymers. 13:1-27.
36. Magde, D., E. Elson, and W. W. Webb. 1972. Thermodynamic fluctuations in a reacting system-measurement by fluorescence correlation spectroscopy. Phys. Rev. Lett. 29:705.
37. Meyer, E. E., K. J. Rosenberg, and J. Israelachvili. 2006. Recent progress in understanding hydrophobic interactions. Proc. Natl. Acad. Sci. USA. 103:15739-15746.
38. Lum, K., D. Chandler, and J. D. Weeks. 1999. Hydrophobicity at small and large length scales. J. Phys. Chem. B. 103:4570-4577.
39. Rice, S. A., and M. Nagasawa. 1961. Polyelectrolyte Solutions. Academic Press, London, UK.
40. Levin, Y. 2002. Electrostatic correlations: from plasma to biology. Rep. Prog. Phys. 65:1577-1632.
41. Khurana, R., and J. B. Udgaonkar. 1994. Equilibrium unfolding studies of barstar: evidence for an alternative conformation which resembles a molten globule. Biochemistry. 33:106-115. (Pubitemid 24046502)
42. Rani, S. A., B. Pitts, and P. S. Stewart. 2005. Rapid diffusion of fluorescent tracers into Staphylococcus epidermidis biofilms visualized by time lapse microscopy. Antimicrob. Agents Chemother. 49:728-732.
43. LeVine, 3rd, H. 1999. Quantification of b-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 309:274-284.
44. Burdick, D., B. Soreghan, M. Kwon, J. Kosmoski, M. Knauer, et al. 1992. Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs. J. Biol. Chem. 267:546-554.
45. Foffi, G., G. D. McCullagh, A. Lawlor, E. Zaccarelli, K. A. Dawson, et al. 2002. Phase equilibria and glass transition in colloidal systems with short-ranged attractive interactions: application to protein crystallization. Phys. Rev. E Stat. Nonlin. Soft Matter Phys. 65:17.
46. 1-42wt. FEBS J. 273:2618-2630.
47. Baldwin, R. L. 1996. How Hofmeister ion interactions affect protein stability. Biophys. J. 71:2056-2063.
48. II. J. Am. Chem. Soc. 128:3540-3542.